129 related articles for article (PubMed ID: 15965487)
41. Cell size: chromosomes get slapped by a midzone ruler.
Ladouceur AM; Ranjan R; Maddox PS
Curr Biol; 2011 May; 21(10):R388-90. PubMed ID: 21601795
[TBL] [Abstract][Full Text] [Related]
42. Defective decatenation checkpoint function is a common feature of melanoma.
Brooks K; Chia KM; Spoerri L; Mukhopadhyay P; Wigan M; Stark M; Pavey S; Gabrielli B
J Invest Dermatol; 2014 Jan; 134(1):150-158. PubMed ID: 23842115
[TBL] [Abstract][Full Text] [Related]
43. A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor function.
Kononenko AV; Bansal R; Lee NC; Grimes BR; Masumoto H; Earnshaw WC; Larionov V; Kouprina N
Nucleic Acids Res; 2014 Dec; 42(21):e164. PubMed ID: 25260588
[TBL] [Abstract][Full Text] [Related]
44. Author Correction: Topoisomerase IIα controls the decatenation checkpoint.
Luo K; Yuan J; Chen J; Lou Z
Nat Cell Biol; 2018 Nov; 20(11):1326-1327. PubMed ID: 30181621
[TBL] [Abstract][Full Text] [Related]
45. Decatenation: fixing your knots.
Clarke DJ
Blood; 2009 Aug; 114(9):1721-2. PubMed ID: 19713475
[TBL] [Abstract][Full Text] [Related]
46. RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.
Guturi KKN; Bohgaki M; Bohgaki T; Srikumar T; Ng D; Kumareswaran R; El Ghamrasni S; Jeon J; Patel P; Eldin MS; Bristow R; Cheung P; Stewart GS; Raught B; Hakem A; Hakem R
Nat Commun; 2016 Aug; 7():12638. PubMed ID: 27558965
[TBL] [Abstract][Full Text] [Related]
47. BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.
Shinagawa H; Miki Y; Yoshida K
Antioxid Redox Signal; 2008 May; 10(5):939-49. PubMed ID: 18162055
[TBL] [Abstract][Full Text] [Related]
48. BAF complexes facilitate decatenation of DNA by topoisomerase IIα.
Dykhuizen EC; Hargreaves DC; Miller EL; Cui K; Korshunov A; Kool M; Pfister S; Cho YJ; Zhao K; Crabtree GR
Nature; 2013 May; 497(7451):624-7. PubMed ID: 23698369
[TBL] [Abstract][Full Text] [Related]
49. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
[TBL] [Abstract][Full Text] [Related]
50. Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
Soliman TN; Keifenheim D; Parker PJ; Clarke DJ
J Cell Biol; 2023 Dec; 222(12):. PubMed ID: 37955972
[TBL] [Abstract][Full Text] [Related]
51. TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells.
Jaiswal AS; Dutta A; Srinivasan G; Yuan Y; Zhou D; Shaheen M; Sadideen DT; Kirby A; Williamson EA; Gupta YK; Olsen SK; Xu M; Loranc E; Mukhopadhyay P; Pertsemlidis A; Bishop AJR; Sung P; Nickoloff JA; Hromas R
Nucleic Acids Res; 2023 Dec; 51(22):12224-12241. PubMed ID: 37953292
[TBL] [Abstract][Full Text] [Related]
52. GINS1 promotes the proliferation and migration of glioma cells through USP15-mediated deubiquitination of TOP2A.
Yang H; Liu X; Zhu X; Zhang M; Wang Y; Ma M; Lv K
iScience; 2022 Sep; 25(9):104952. PubMed ID: 36065190
[TBL] [Abstract][Full Text] [Related]
53. Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells.
Lockwood N; Martini S; Lopez-Pardo A; Deiss K; Segeren HA; Semple RK; Collins I; Repana D; Cobbaut M; Soliman T; Ciccarelli F; Parker PJ
Cancer Res; 2022 May; 82(9):1762-1773. PubMed ID: 35247890
[TBL] [Abstract][Full Text] [Related]
54. BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ.
Bunch H; Jeong J; Kang K; Jo DS; Cong ATQ; Kim D; Kim D; Cho DH; Lee YM; Chen BPC; Schellenberg MJ; Calderwood SK
Open Biol; 2021 Oct; 11(10):210221. PubMed ID: 34610268
[TBL] [Abstract][Full Text] [Related]
55. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
56. DNA damage repair system in C57BL/6 J mice is evolutionarily stable.
Wang X; Wang SM
BMC Genomics; 2021 Sep; 22(1):669. PubMed ID: 34535077
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.
Leung E; Hazrati LN
Brain Commun; 2021; 3(2):fcab117. PubMed ID: 34222870
[TBL] [Abstract][Full Text] [Related]
58. Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours.
Fernando M; Duijf PHG; Proctor M; Stevenson AJ; Ehmann A; Vora S; Skalamera D; Adams M; Gabrielli B
Oncogenesis; 2021 May; 10(5):41. PubMed ID: 33993200
[TBL] [Abstract][Full Text] [Related]
59. Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.
Arroyo M; Cañuelo A; Calahorra J; Hastert FD; Sánchez A; Clarke DJ; Marchal JA
FEBS J; 2020 Nov; 287(22):4933-4951. PubMed ID: 32144855
[TBL] [Abstract][Full Text] [Related]
60. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
Tarsounas M; Sung P
Nat Rev Mol Cell Biol; 2020 May; 21(5):284-299. PubMed ID: 32094664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
